Edwards lifesciences to sell critical care to bd

Irvine, ca--(business wire)--edwards lifesciences (nyse: ew) today announced it has entered into a definitive agreement to sell its critical care product group to bd (becton, dickinson and company) (nyse: bdx), in an all-cash transaction valued at $4.2 billion. with this agreement, edwards is no longer pursuing the previously announced spin-off of critical care. edwards will use the after-tax cash proceeds to fund strategic growth investments. the sale enhances edwards' balance sheet flexibilit.
BDX Ratings Summary
BDX Quant Ranking